Two cases of ceftriaxone‐induced encephalopathy treated by hemoperfusion in hemodialysis patients

Ceftriaxone is a third‐generation cephalosporin commonly used to treat infection. However, encephalopathy is an emerging adverse effect of ceftriaxone infusion. These patients present with various symptoms, including those of neurotoxicity, that typically resolve 1 week after discontinuation of ceft...

Descripción completa

Detalles Bibliográficos
Autores principales: Onogi, Chikao, Osada, Akinori, Imai, Kentaro, Mimura, Tetsushi, Saka, Yosuke, Urahama, Yoshimichi, Oishi, Hideto, Naruse, Tomohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545014/
https://www.ncbi.nlm.nih.gov/pubmed/35441472
http://dx.doi.org/10.1111/hdi.13018
Descripción
Sumario:Ceftriaxone is a third‐generation cephalosporin commonly used to treat infection. However, encephalopathy is an emerging adverse effect of ceftriaxone infusion. These patients present with various symptoms, including those of neurotoxicity, that typically resolve 1 week after discontinuation of ceftriaxone. We experienced two cases of ceftriaxone‐induced encephalopathy that were successfully treated by rapid removal of ceftriaxone by hemoperfusion.

Ejemplares similares